The eighth edition of our Life Sciences seminar will be held on 31 March and will focus on biosimilars. Biological medicines now account for 20% of the pharmaceutical market in the world and are expanding extremely rapidly. The biosimilars market should fully take off by 2020, notably with more patents reaching expiry.
Development of a biosimilar medicine, research, marketing authorizations, pricing and substitution, anticipation of litigation to come... Professor Loïc Guillevin (President of the French Commission on Transparency), Dr Frédéric Girard (Deputy Chairman of GEMME), Suzanne Delvaque (Senior Counsel Global Legal Biopharmaceuticals at Sandoz International) as well as our partners in Paris and Washington will present their visions and experience.